Claus Torp Jensen - 03 May 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF INNOVATION OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 03 May 2022
Net transactions value: -$77,620
Form type: 4
Filing time: 05 May 2022, 16:10:18 UTC
Previous filing: 02 Mar 2022
Next filing: 03 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+5,616			5,616	03 May 2022	Direct	F1
transaction	TDOC	Common Stock	Sale	$77,620	-2,051	-37%	$37.84	3,565	04 May 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-5,616	-33%	$0.000000	11,233	03 May 2022	Common Stock	5,616		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On May 3, 2021, the reporting person was granted 16,849 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.